Avellino Labs
Scott Korney joined Avellino in 2012 and holds the distinction as the company’s first US employee. He has led several different areas of the company, including as Chief Operating Officer (2012 – 2020); Head of U.S. Operations (2021); and currently serves as Global Head of Facilities and Real Estate. His talents and dedication have helped Avellino grow from a small start-up to a global biotechnology company with hundreds of employees. Scott brings 40 years of experience in the science and biotechnology industry as an entrepreneur, as he founded two different businesses; has supported many early-stage business ventures; and also led successful global teams at three different Fortune 500 companies: ARCO, Johnson & Johnson and Pfizer. He has a Bachelor of Applied Science in Agronomy and Crop Science from California State Polytechnic University-Pomona.
This person is not in any offices
Avellino Labs
Avellino Labs is a global leader in gene therapy and molecular diagnostics, and the pioneer in personalized medicine for eye care. Avellino Labs is pioneering CRISPR gene editing to manage and potentially cure inherited diseases. Avellino Labs continues to expand its diagnostics capabilities, building on the success of the world's first DNA test to confirm the presence of genetic indicators that are positively associated with corneal dystrophies, providing life-changing information for patient treatment decisions and follow up care. Avellino Labs is headquartered in Silicon Valley, California, with operations in Korea, Japan, China and the UK.